Cargando…
Radiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study
BACKGROUND: Small cell carcinoma of the esophagus (SCCE) is characterized by its progressive feature and poor prognosis. There is no consensus on a standard therapeutic modality for SCCE. In this study, we aimed to characterize the outcomes of primary SCCE patients treated by radiation therapy as pa...
Autores principales: | Chen, Baoqing, Yang, Han, Ma, Huali, Li, Qiaoqiao, Qiu, Bo, Hu, Yonghong, Zhu, Yujia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873724/ https://www.ncbi.nlm.nih.gov/pubmed/31752922 http://dx.doi.org/10.1186/s13014-019-1415-9 |
Ejemplares similares
-
Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy
por: Chi, Dongmei, et al.
Publicado: (2021) -
Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
por: Jiang, Hui, et al.
Publicado: (2023) -
Survival outcomes and prognostic factors of primary small cell carcinoma of the esophagus
por: Miao, Huikai, et al.
Publicado: (2021) -
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
por: Jiang, Hui, et al.
Publicado: (2023) -
Prognostic value of biomarkers in primary small cell carcinoma of the esophagus
por: Wang, Yan, et al.
Publicado: (2020)